KRASG12C IN-16
Product Specifications
Target
Kras|||Apoptosis|||p38 MAPK|||mTOR|||PI3K|||Ras
Related Pathways
Apoptosis|||GPCR/G Protein|||MAPK|||PI3K/Akt/mTOR signaling
Bioactivity
KRASG12C IN-16 (Compound SK-17) is a selective, covalent, and orally active KRASG12C inhibitor. It can induce apoptosis and effectively prevent the activation of the MAPK and PI3K/mTOR signaling pathways. Additionally, KRASG12C IN-16 exhibits antitumor activity against pancreatic cancer.
Molecular Formula
C28H35ClN8O2
Molecular Weight
551.08
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6481494-01 0.2 mL
ILK, Phosphorylated (Thr173) (Integrin-linked Protein Kinase, ILK-1, ILK-2, 59kD Serine/Threonine-protein Kinase, p59ILK, ILK1, ILK2) (AP)
Ask
View Details MBS6481494-02 5x 0.2 mL
ILK, Phosphorylated (Thr173) (Integrin-linked Protein Kinase, ILK-1, ILK-2, 59kD Serine/Threonine-protein Kinase, p59ILK, ILK1, ILK2) (AP)
Ask
View Details 